Works by Hideo Nakajima


Results: 55
    1
    2
    3
    4
    5

    On the Anisotropy of Lotus-Type Porous Copper.

    Published in:
    Advanced Engineering Materials, 2012, v. 14, n. 3, p. 144, doi. 10.1002/adem.201100205
    By:
    • Fiedler, Thomas;
    • Veyhl, Christoph;
    • Belova, Irina Veniaminovna;
    • Tane, Masakazu;
    • Nakajima, Hideo;
    • Bernthaler, Timo;
    • Merkel, Markus;
    • Öchsner, Andreas;
    • Murch, Graeme Elliott
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    New pathogenesis and the classification in scaphocephaly.

    Published in:
    Journal of Plastic Surgery & Hand Surgery (Taylor & Francis Ltd), 2014, v. 48, n. 1, p. 24, doi. 10.3109/2000656X.2013.793602
    By:
    • Sakamoto, Yoshiaki;
    • Nakajima, Hideo;
    • Tamada, Ikkei;
    • Miwa, Tomoru;
    • Kishi, Kazuo;
    • Yoshida, Kazunari
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

    Published in:
    Journal of Gastroenterology, 2012, v. 47, n. 3, p. 321, doi. 10.1007/s00535-011-0484-9
    By:
    • Shimasaki, Takeo;
    • Ishigaki, Yasuhito;
    • Nakamura, Yuka;
    • Takata, Takanobu;
    • Nakaya, Naoki;
    • Nakajima, Hideo;
    • Sato, Itaru;
    • Zhao, Xia;
    • Kitano, Ayako;
    • Kawakami, Kazuyuki;
    • Tanaka, Takuji;
    • Takegami, Tsutomu;
    • Tomosugi, Naohisa;
    • Minamoto, Toshinari;
    • Motoo, Yoshiharu
    Publication type:
    Article
    48
    49

    Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.

    Published in:
    Investigational New Drugs, 2023, v. 41, n. 1, p. 122, doi. 10.1007/s10637-023-01328-9
    By:
    • Ishikawa, Emi;
    • Yokoyama, Yuta;
    • Chishima, Haruna;
    • Kasai, Hidefumi;
    • Kuniyoshi, Ouki;
    • Kimura, Motonori;
    • Hakamata, Jun;
    • Nakada, Hideo;
    • Suehiro, Naoya;
    • Nakaya, Naoki;
    • Nakajima, Hideo;
    • Ikemura, Shinnosuke;
    • Kawada, Ichiro;
    • Yasuda, Hiroyuki;
    • Terai, Hideki;
    • Jibiki, Aya;
    • Kawazoe, Hitoshi;
    • Soejima, Kenzo;
    • Muramatsu, Hiroshi;
    • Suzuki, Sayo
    Publication type:
    Article
    50